Foley Advises SHINE Medical Technologies in Merger with Phoenix LLC

22 April 2021 Media Contact: Jen Dilworth News

Foley & Lardner LLP served as lead legal counsel to Illuminated Holdings, Inc. and its wholly-owned subsidiary, SHINE Medical Technologies LLC, a next-generation nuclear technology company, in its acquisition of Phoenix LLC, a manufacturer of commercial neutron generators. Under the terms of the merger, which was completed on April 15, 2021, Phoenix has become a wholly-owned subsidiary of Illuminated.

SHINE is focused on advancing fusion technologies to deliver on the long-term promise of clean fusion energy and, ultimately, benefit the planet and humankind. This merger is part of SHINE’s four-phase plan for producing clean energy from fusion – at each phase, SHINE is focused on building additional capacity and capability while deepening scientific understanding of fusion technology as it progresses to clean fusion energy production.

The Foley team was led by Paul Wrycha and Jason Hille and included Eric Lauria-Banta, Katie Conterio and Austin Kissinger (corporate); John Palmer (tax); Joshua Agen and Kathleen Bardunias (employee benefits); Edward Hammond and Natalie Neals (finance); Erin Toomey (government contacts); Carmen Decot (labor and employment); Christopher Swift (government solutions); Gregory Neppl (antitrust); Ethan Lenz (insurance); and Hillary Vedvig (environmental).


Act Now: Employer Obligations Under New York HERO Act
02 August 2021
Labor & Employment Law Perspectives
$15 Minimum Wage for Federal Government Contractors Starting in January 2022
02 August 2021
Labor & Employment Law Perspectives
Supreme Court Limits Patent Assignor Estoppel
02 August 2021
Review of Recent Whistleblower Developments
30 July 2021
Legal News: Whistleblower Developments
30th Annual Law of Product Distribution & Franchise Seminar
29 September | 7 & 20 October 2021
Milwaukee | Chicago | Dallas
7th National Telehealth Summit
4-5 October 2021
Miami Beach, FL
AHLA Fraud & Compliance Forum
21-22 September 2021
Baltimore, MD
2nd Clinical Trial Agreements Forum
16-17 September 2021
Online Livestream